Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-03-2017 | Letter to the Editor

A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism

Author: Jean-Claude Baron

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 3/2017

Excerpt

Dear Sir, …

Niccolini F, Politis M. A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism. Eur J Nucl Med Mol Imaging. 2016;43:2244–54. doi:10.1007/s00259-016-3464-8.CrossRefPubMedPubMedCentral

D’Antona R, Baron JC, Samson Y, Serdaru M, Viader F, Agid Y, et al. Subcortical dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy. Brain. 1985;108(Pt 3):785–99.CrossRefPubMed

Foster NL, Gilman S, Berent S, Morin EM, Brown MB, Koeppe RA. Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography. Ann Neurol. 1988;24:399–406. doi:10.1002/ana.410240308.CrossRefPubMed

Goffinet AM, De Volder AG, Gillain C, Rectem D, Bol A, Michel C, et al. Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy. Ann Neurol. 1989;25:131–9. doi:10.1002/ana.410250205.CrossRefPubMed

Leenders KL, Frackowiak RS, Lees AJ. Steele-Richardson-Olszewski syndrome. Brain energy metabolism, blood flow and fluorodopa uptake measured by positron emission tomography. Brain. 1988;111(Pt 3):615–30.CrossRefPubMed

Karbe H, Grond M, Huber M, Herholz K, Kessler J, Heiss WD. Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography. J Neurol. 1992;239:98–102.CrossRefPubMed

Blin J, Baron JC, Dubois B, Pillon B, Cambon H, Cambier J, et al. Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations. Arch Neurol. 1990;47:747–52.CrossRefPubMed

Baron JC, Maziere B, Loc’h C, Cambon H, Sgouropoulos P, Bonnet AM, et al. Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy. J Cereb Blood Flow Metab. 1986;6:131–6. doi:10.1038/jcbfm.1986.26.CrossRefPubMed

Baron JC, Maziere B, Loc’h C, Sgouropoulos P, Bonnet AM, Agid Y. Progressive supranuclear palsy: loss of striatal dopamine receptors demonstrated in vivo by positron tomography. Lancet. 1985;1:1163–4.CrossRefPubMed

10.

Bhatt MH, Snow BJ, Martin WR, Peppard R, Calne DB. Positron emission tomography in progressive supranuclear palsy. Arch Neurol. 1991;48:389–91.CrossRefPubMed

11.

Gilman S, Markel DS, Koeppe RA, Junck L, Kluin KJ, Gebarski SS, et al. Cerebellar and brainstem hypometabolism in olivopontocerebellar atrophy detected with positron emission tomography. Ann Neurol. 1988;23:223–30. doi:10.1002/ana.410230303.CrossRefPubMed

12.

Rosenthal G, Gilman S, Koeppe RA, Kluin KJ, Markel DS, Junck L, et al. Motor dysfunction in olivopontocerebellar atrophy is related to cerebral metabolic rate studied with positron emission tomography. Ann Neurol. 1988;24:414–9. doi:10.1002/ana.410240310.CrossRefPubMed

13.

Eidelberg D, Takikawa S, Moeller JR, Dhawan V, Redington K, Chaly T, et al. Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson’s disease. Ann Neurol. 1993;33:518–27. doi:10.1002/ana.410330517.CrossRefPubMed

14.

Garraux G, Phillips C, Schrouff J, Kreisler A, Lemaire C, Degueldre C, et al. Multiclass classification of FDG PET scans for the distinction between Parkinson’s disease and atypical parkinsonian syndromes. Neuroimage Clin. 2013;2:883–93. doi:10.1016/j.nicl.2013.06.004.CrossRefPubMedPubMedCentral

15.

Poston KL, Tang CC, Eckert T, Dhawan V, Frucht S, Vonsattel JP, et al. Network correlates of disease severity in multiple system atrophy. Neurology. 2012;78:1237–44. doi:10.1212/WNL.0b013e318250d7fd.CrossRefPubMedPubMedCentral

Title: A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism
Author: Jean-Claude Baron
Publication date: 01-03-2017
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 3/2017
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-016-3596-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2017

“la synoviorthèse” can more than synovitis!

Erratum to: The need of standardization and of large clinical studies in an emerging indication of [18 F]FDG PET: the autoimmune encephalitis

Erratum to: Role of PET/CT in malignant pediatric lymphoma

Computed-tomography-guided anatomic standardization for quantitative assessment of dopamine transporter SPECT

William C. Klingesmith III: The Mathematics and Biology of the Biodistribution of Radiopharmaceuticals: A Clinical Perspective

On the accuracy and reproducibility of a novel probabilistic atlas-based generation for calculation of head attenuation maps on integrated PET/MR scanners